
ELIXXER LTD
Share · CA28660W2004 · A3DWCQ (XTSX)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ELIXXER LTD
No Price
28.04.2026 20:00
Current Prices from ELIXXER LTD
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
ELIXF
|
USD
|
28.04.2026 20:00
|
0,03 USD
| 0,00 USD |
Company Profile for ELIXXER LTD Share
Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cannabis-related businesses, which are fully licensed for cultivation, production, and/or sale of medical and specialty cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada.
Company Data
Name ELIXXER LTD
Company Elixxer Ltd.
Website
https://www.elixxer.com
Primary Exchange
Frankfurt
Frankfurt
WKN A3DWCQ
ISIN CA28660W2004
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Karim Mecklai
Market Capitalization 23 Mio
Country Canada
Currency EUR
Employees -
Address 100 Boulevard Rene- Levesque Ouest, H5B 4N4 Montreal
IPO Date 2017-12-14
Stock Splits
| Date | Split |
|---|---|
| 10.02.2022 | 1:100 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | ELIXF |
More Shares
Investors who hold ELIXXER LTD also have the following shares in their portfolio:

